MSI-1 administration significantly alleviated lung lesion, indicating that MIS-1 could reverse lung injury caused by penicillin-resistant E. coli, indicating that MSI-1 attenuates acute systemic E. coli infection in mice. Here, MSI1 is linked to escherichia coli infection.